Document is current
Any future updates will be listed below
-
Authors
Kudo, Takahiro https://orcid.org/0000-0003-4708-8049
Arai, Katsuhiro
Iwama, Itaru
Hagiwara, Shin-ichiro
Ishige, Takashi
Yokoyama, Koji
Kakuta, Fumihiko
Jimbo, Keisuke
Kondou, Hiroki
Takaki, Yugo
Kurasawa, Shingo
Fujikawa, Hiroki
Koike, Yuhki
Hirai, Fumihito
Ashizuka, Shinya
Watanabe, Kenji
Shimizu, Toshiaki
Hisamatsu, Tadakazu
- License Information
-
More Information
Article History
Received: 22 April 2025
Accepted: 1 June 2025
First Online: 2 July 2025
Declarations
:
: Takashi Ishige received a consulting fee from AbbVie GK. Keisuke Jimbo received a grant Japan Society for the Promotion of Science KANENHI Grant-in-Aid for Scientific Research (c) [grant number 23K07361]. Fumihito Hirai received a consulting fee from AbbVie GK, EA pharma Co. Ltd., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co. Ltd., Eli Lilly Japan K.K., MSD Co. Ltd., and a grant support from AbbVie GK, EA pharma Co. Ltd., Kyorin Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co. Ltd.. Kenji Watanabe received a lecture fee from Takeda Pharmaceutical Co. Ltd., AbbVie GK, EA pharma Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co. Ltd., JIMRO Co. Ltd.. Toshiaki Shimizu received a research grant from The Food Science Institute Foundation (Ryoshoku-kenkyukai). Tadakazu Hisamatsu received a grant support from Mitsubishi Tanabe Pharma Corporation, EA pharma Co. Ltd., AbbVie GK, JIMRO Co. Ltd., Zeria Pharmaceutical Co. Ltd., Kyorin Pharmaceutical Co. Ltd., Nippon Kayaku Co. Ltd., Takeda Pharmaceutical Co. Ltd., Pfizer Inc., Mochida Pharmaceutical Co. Ltd., Boston Scientific Corporation, Kissei Pharmaceutical Co. Ltd., a consulting fee from Mitsubishi Tanabe Pharma Corporation, EA pharma Co. Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Pfizer Inc., Eli Lilly, Gilead Sciences, Bristol Myers Squibb, Abivax, and a lecture fee from Mitsubishi Tanabe Pharma Corporation, AbbVie GK, EA pharma Co. Ltd., Kyorin Pharmaceutical Co. Ltd., JIMRO Co., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co. Ltd., Pfizer Inc., Kissei Pharmaceutical Co. Ltd. All other authors declare no conflict of interest.
